ACM

Aquilo Capital Management Portfolio holdings

AUM $37.1M
This Quarter Return
-5.2%
1 Year Return
-36.49%
3 Year Return
+1.32%
5 Year Return
+39.69%
10 Year Return
–
AUM
$88.1M
AUM Growth
+$88.1M
Cap. Flow
-$30.3M
Cap. Flow %
-34.34%
Top 10 Hldgs %
100%
Holding
13
New
–
Increased
5
Reduced
2
Closed
2

Top Buys

1
PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
$5.14M
2
GLPG icon
Galapagos
GLPG
$1.53M
3
QURE icon
uniQure
QURE
$1.05M
4
PRQR icon
ProQR Therapeutics
PRQR
$477K
5
BCYC
Bicycle Therapeutics
BCYC
$336K

Top Sells

1
ARWR icon
Arrowhead Research
ARWR
$14.8M
2
SYBX icon
Synlogic
SYBX
$9.5M
3
FATE icon
Fate Therapeutics
FATE
$8.23M
4
MRUS icon
Merus
MRUS
$6.29M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MRUS icon
1
Merus
MRUS
$4.98B
$18.5M 13.04%
1,038,746
-352,751
-25% -$6.29M
QURE icon
2
uniQure
QURE
$896M
$15.4M 10.84%
391,199
+26,603
+7% +$1.05M
SPRO icon
3
Spero Therapeutics
SPRO
$116M
$12.2M 8.62%
1,154,356
– –
PVLA
4
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$10.1M 7.1%
2,958,243
+1,506,393
+104% +$5.14M
BCYC
5
Bicycle Therapeutics
BCYC
$511M
$8.74M 6.15%
767,026
+29,497
+4% +$336K
GLPG icon
6
Galapagos
GLPG
$2.07B
$8.68M 6.11%
56,840
+10,000
+21% +$1.53M
XENE icon
7
Xenon Pharmaceuticals
XENE
$2.98B
$8.57M 6.04%
951,527
– –
PRQR icon
8
ProQR Therapeutics
PRQR
$237M
$4.79M 3.37%
831,661
+82,800
+11% +$477K
FATE icon
9
Fate Therapeutics
FATE
$120M
$1.12M 0.79%
72,273
-529,823
-88% -$8.23M
ARWR icon
10
Arrowhead Research
ARWR
$3.05B
– –
-557,455
Closed -$14.8M
IBB icon
11
iShares Biotechnology ETF
IBB
$5.6B
– –
0
– –
SYBX icon
12
Synlogic
SYBX
$17M
– –
-1,043,922
Closed -$9.5M
XBI icon
13
SPDR S&P Biotech ETF
XBI
$5.07B
– –
0
– –